Compounds > carbendazim
Page last updated: 2024-08-22

carbendazim and Breast Neoplasms

carbendazim has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atalay, PB; Kuku, G; Tuna, BG1
Cox, C; Jordan, MA; Wilson, L; Yenjerla, M1
Camden, JB; Davidson, K; Hammond, LA; Izbicka, E; Lawrence, R; Von Hoff, DD; Weitman, S1

Other Studies

3 other study(ies) available for carbendazim and Breast Neoplasms

ArticleYear
Effects of carbendazim and astaxanthin co-treatment on the proliferation of MCF-7 breast cancer cells.
    In vitro cellular & developmental biology. Animal, 2019, Volume: 55, Issue:2

    Topics: Benzimidazoles; Breast Neoplasms; Carbamates; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Female; G2 Phase; Humans; Intracellular Space; MCF-7 Cells; Mitosis; Reactive Oxygen Species; Xanthophylls

2019
Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 328, Issue:2

    Topics: Benzimidazoles; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell Proliferation; Colchicine; Dose-Response Relationship, Drug; Humans; Microtubules; Mitosis; Tubulin

2009
Exploring the mechanisms of action of FB642 at the cellular level.
    Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Breast Neoplasms; Carbamates; Cell Cycle; Cell Division; Colorectal Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genes, p53; Humans; Leukemia; Leukemia, Experimental; Male; Melanoma, Experimental; Mice; Neoplasm Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2001